IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2018-06-01. The firm has sold all of its assets. The company is not engaged in any business operations.
IMV Inc の最大収益セグメントは Highly Engineered Industrial Process Heating Solutions で、最新の利益発表における収益は 494,629,000 です。地域別に見ると、United States and Latin America が IMV Inc の主要市場であり、収益は 256,293,000 です。